WHO ICTRP trial
The effect of Granolocyte Colony Stimulating Factor in treatment of Amyotrophic…
IRCT201207238509N2 · Iranian Registry of Clinical Trials (IRCT) · Not Recruiting
Key facts
| Trial ID | IRCT201207238509N2 |
|---|---|
| Public title | The effect of Granolocyte Colony Stimulating Factor in treatment of Amyotrophic Lateral Sclerosis |
| Scientific title | The effect of Granolocyte Colony Stimulating Factor (GCSF) in the treatment of Amyotrophic Lateral Sclerosis (ALS) patients referred to Tehran Imam Khomeini and Shariati hospital centers in 2012. |
| Primary sponsor | Iranian neurology research center of Tehran University of Medical Sciences |
| Secondary sponsors | immunology research center of Tehran University of Medical Sciences |
| Registry | Iranian Registry of Clinical Trials (IRCT) |
| Recruitment status | Not Recruiting |
| Study type | interventional |
| Countries | Iran (Islamic Republic of);Iran (Islamic Republic of) |
| Conditions | amyotrophic lateral sclerosis. Diseases of the nervous system;Diseases of the nervous system |
| Interventions | Intervention 1: normal saline 0.01 ml/kg/day for 5 days subcutaneously. Intervention 2: Granolocyte Colony Stimulating Factor 10 microgram/ kg/ day for 5 days subcutaneously.;Placebo;Treatment - Drugs;normal saline 0.01 ml/kg/day for 5 days… |
| Registration date | Aug 17, 2012 |
| Target size | 40 |
| Registry page | irct.behdasht.gov.ir |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: